According to the World Health Organization (WHO), cancer is a leading cause of mortality worldwide, and accounted for over 10 million deaths in 2020. The organization also stated that CVDs account for nearly 17.9 million deaths each year.

Receive a Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/vascular-imaging-systems-market/report-sample

As per the United Nations Department of Economic and Social Affairs (UNDESA), the population of individuals aged 65 years or above will reach over 1.5 billion in 2050. The aging population is highly prone to CVDs, such as heart failure, stroke, valvar heart disease, rheumatic heart disease, aortic aneurysms, cardiomyopathy, peripheral artery disease, congenital heart disease, heart arrhythmia, venous thrombosis, and caritas. Old people experience slow heart rate, due to the slight increase in heart size and deposition of fat in the heart.
Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=vascular-imaging-systems-market

The aforementioned products are used in diagnostic centers, specialty clinics, and hospitals. These healthcare facilities use the products in their cardiology, neurology, and oncology departments. According to P&S Intelligence, hospitals are the leading consumers of these systems, as they record the highest inrush of patients. The devices and equipment used at these healthcare settings are offered by Siemens AG, Hitachi Ltd., Canon Inc., General Electric Company, Koninklijke Philips N.V., Orthoscan Inc., Carestream Health Inc., Fujifilm Corporation, Hologic Inc., Shimazdu Corporation, and Esaote S.P.A.